Andreas Tschirky has been named as leader of BioDuro, the Beijing, China-based drug discovery services business acquired by PPD. Tschirky worked at Roche for 11 years and has also held positions at Paul-Scherrer Institute.
Australia-based Trident Clinical Research has appointed David Fuller as chief medical officer. Fuller last worked at Arana Therapeutics and has also held positions at Genzyme, Orphan Medical and CeNeS.
Sean Maki has joined Agilux Laboratories as associate director of its newly launched in-vivo pharmacokinetic (PK) and pharmacodynamic (PD) services division. Maki previously worked at Concord Biomedical Sciences and Emerging Technologies and Charles River Laboratories.
Supply chain business Tompkins Associates has named John Musante as vice president (VP) of pharmaceuticals and medical device services. Before joining Tompkins Musante worked at Sentient, Ascend Therapeutics, PDI, GlaxoSmithKline and Rockett, Burkhead and Winslow.
Rick Coulon has been appointed as director of business development at PharmOptima. In a 20 year career in pharma sales, marketing and business development Coulon has worked at Ciba Vision, Akorn, Mallinckrodt Pharmaceuticals, Stonebridge Pharma and Auriga Laboratories.
Clinical Trials of America has hired Donald Dickerson as president. Dickerson has 25 years of experience working in technology and service companies, including spells at bioRASI, JP Morgan Chase & Co and Boeing Capital.
William DeMaio has joined Ricerca Biosciences as senior director of the drug metabolism and pharmacokinetics (DMPK) department. DeMaio has previously worked at RET Consultants, Pfizer and Wyeth.
PDI has named Jade Shields Sr as VP of corporate compliance and ethics. Shields worked at Johnson & Johnson for nearly 20 years, most recently as senior director in the office of compliance for the consumer pharmaceuticals division.
Tony Horton has been appointed as VP of quality assurance at Pharmaceutics International. Horton has 35 years of quality assurance experience working at companies including BenVenue, Mylan Laboratories, Gensia Sicor Pharmaceuticals, Fujisawa and Baxter Labs.